title: Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications.
authors.forename: Christian
authors.initials: C
authors.lastname: Dohna-Schwake
authors.forename: Brunhilde
authors.initials: B
authors.lastname: Schweiger
authors.forename: Ursula
authors.initials: U
authors.lastname: Felderhoff-Müser
authors.forename: Melanie
authors.initials: M
authors.lastname: Fiedler
authors.forename: Gernot M
authors.initials: GM
authors.lastname: Kaiser
authors.forename: Andreas
authors.initials: A
authors.lastname: Paul
authors.forename: Patrick
authors.initials: P
authors.lastname: Gerner
authors.forename: Elke
authors.initials: E
authors.lastname: Lainka
authors.forename: Peter F
authors.initials: PF
authors.lastname: Hoyer
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000235:genetics / Q000302:isolation & purification; D007251:Influenza, Human / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D007262:Infusions, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects* / Q000276:immunology; D012367:RNA, Viral / Q000302:isolation & purification; D012128:Respiratory Distress Syndrome / Q000175:diagnosis / Q000209:etiology; D016896:Treatment Outcome; D053243:Zanamivir / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D053243:Zanamivir